[go: up one dir, main page]

AU3593095A - Method of treatment of human immunodeficiency virus (hiv) infection - Google Patents

Method of treatment of human immunodeficiency virus (hiv) infection

Info

Publication number
AU3593095A
AU3593095A AU35930/95A AU3593095A AU3593095A AU 3593095 A AU3593095 A AU 3593095A AU 35930/95 A AU35930/95 A AU 35930/95A AU 3593095 A AU3593095 A AU 3593095A AU 3593095 A AU3593095 A AU 3593095A
Authority
AU
Australia
Prior art keywords
hiv
infection
treatment
immunodeficiency virus
human immunodeficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35930/95A
Inventor
Janice E Clements
Michael Murphey-Corb
M. Christine Zink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Tulane University
Original Assignee
Johns Hopkins University
Tulane University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University, Tulane University filed Critical Johns Hopkins University
Publication of AU3593095A publication Critical patent/AU3593095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/1145—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU35930/95A 1994-09-23 1995-09-19 Method of treatment of human immunodeficiency virus (hiv) infection Abandoned AU3593095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31142494A 1994-09-23 1994-09-23
US311424 1994-09-23
PCT/US1995/011943 WO1996009066A2 (en) 1994-09-23 1995-09-19 Method of treatment of human immunodeficiency virus (hiv) infection

Publications (1)

Publication Number Publication Date
AU3593095A true AU3593095A (en) 1996-04-09

Family

ID=23206813

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35930/95A Abandoned AU3593095A (en) 1994-09-23 1995-09-19 Method of treatment of human immunodeficiency virus (hiv) infection

Country Status (3)

Country Link
EP (1) EP0784484A2 (en)
AU (1) AU3593095A (en)
WO (1) WO1996009066A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1141313A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9305759D0 (en) * 1993-03-19 1993-05-05 Medical Research Council And T Hiv therapy method and agents

Also Published As

Publication number Publication date
WO1996009066A3 (en) 1996-05-23
EP0784484A2 (en) 1997-07-23
WO1996009066A2 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
EP0831873A4 (en) The treatment of hiv and other viral infections using combinatory therapy
AP9901661A0 (en) Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases
AU4028895A (en) Vaccine and treatment method of Human Immunodeficiency Virus
AU1224100A (en) Reference clones and sequences for non-subtype b isolates of human immunodeficiency virus type 1
AU4088697A (en) Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU3413389A (en) Method of treating retrovirus infection
AU658987B2 (en) Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection
AU5848794A (en) Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
AU5758594A (en) Treatment of viral infections
EP1202750A4 (en) Method of treating hiv infection and related secondary infections thereof
AU4602897A (en) Method for treatment of immunodeficiency virus infection
AU7465696A (en) Synthetic vaccine for protection against human immunodeficiency virus infection
AU5568290A (en) Method of suppressing hiv infection
HRP960045B1 (en) Combination therapy for hiv infection
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
AU9495098A (en) Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection
ZA972722B (en) Method for prevention and treatment of viral infectious diseases.
ZA9510108B (en) Composition and method for prevention and treatment of HIV-1 infection
AU6877991A (en) A method of inactivating human immunodeficiency virus
AU3530395A (en) Treatment of viral infections
AU2473695A (en) Method of slowing the progression of hiv infection
NO965591D0 (en) Combination treatment of HIV infection
AU5085693A (en) Method of treating epstein-barr virus infection
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus